国药现代 (600420)
Shanghai Shyndec Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 134117.27
- Circulating A-Shares(W): 134117.27
- Earnings Per Share(RMB): 0.5974
- Net Assets Per Share(RMB): 10.1689
- Operating Revenue(W RMB): 692039.32
- Total Profit(W RMB): 111548.91
- **Net Profit Attributable to Parent(W RMB) **: 80117.16
- Net Profit Growth Rate(%): -16.07
- Weighted Return on Equity(%): 5.9300
- Operating Cash Flow Per Share(RMB): 0.8510
- Undistributed Profit Per Share(RMB): 4.9539
- Capital Reserve Per Share(RMB): 3.8870
2. Main Business
The main business covers:
- Development, production, and operation of pharmaceutical products
- Agency sales of pharmaceutical products
3. Company Basic Information
- Company Name: Shanghai Shyndec Pharmaceutical Co., Ltd.
- Listing Date: 2004-06-16
- Industry: Pharmaceutical Manufacturing
- Address: No. 378 Jianlu Road, Pudong New Area, Shanghai
- Website: https://www.shyndec.com
- Company Profile: Shanghai Shyndec Pharmaceutical Co., Ltd. was established on December 20, 2000, approved by the former State Economic and Trade Commission (Document No. [2000]1139), and jointly initiated by five promoters including Shanghai Pharmaceutical Industry Research Institute. The company was established through a "whole change" method based on the original Shanghai Modern Pharmaceutical Co., Ltd. The registered capital is 54.19194 million yuan. As approved by the industrial and commercial administration department, the company's business scope includes: manufacturing of pharmaceuticals and health products, wholesale of pharmaceutical raw materials and excipients and pharmaceutical machinery, research and development, technology transfer, technical consulting, technical services, and technical training of pharmaceuticals, health products and other products (the above business scope involves licensed operations must operate with permits).
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Pharmaceutical Industry Research Institute Co., Ltd. | General Legal Person | 23951.26 | 17.86 |
| 2 | China National Pharmaceutical Investment Co., Ltd. | General Legal Person | 17400.56 | 12.97 |
| 3 | China National Medicines Guodao Co., Ltd. | General Legal Person | 16714.22 | 12.46 |
| 4 | China National Pharmaceutical Group Co., Ltd. | General Legal Person | 15309.16 | 11.41 |
| 5 | Sinopharm Group Co., Ltd. | General Legal Person | 1906.84 | 1.42 |
| 6 | Shandong State-owned Asset Investment Holding Co., Ltd. | General Legal Person | 1583.46 | 1.18 |
| 7 | Shanghai Guangci Medical High-Tech Co., Ltd. | General Legal Person | 1252.00 | 0.93 |
| 8 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 861.75 | 0.64 |
5. Concept Sectors
- Childcare Concept
- Vitamins
- Generic Drugs
- Medical Aesthetics Concept
- NMN Concept
- Helicobacter Pylori
- Assisted Reproduction
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
- DeepSeek
- Margin Trading & Securities Lending
- High-Performance Stocks
- Pension Funds
- Free Cash Flow
- CSI Central SOEs
- SSE Mixed-Ownership Reform
- State-Owned Enterprise Reform
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public market information